Czerniak
Diagnostyka i diagnoza

Czerniak, stanowiący około 1% nowotworów skóry, jest odpowiedzialny za większość zgonów z powodu nowotworów skórnych, z prognozowanymi w USA na 2025 rok 104 960 nowymi przypadkami i 8 430 zgonami. Diagnostyka opiera się na badaniu klinicznym z wykorzystaniem kryteriów ABCDE oraz dermatoskopii, mikroskopii konfokalnej, OCT i fotografii całego ciała. Biopsja wycinająca pozostaje złotym standardem, umożliwiając ocenę grubości Breslowa, kluczowego czynnika prognostycznego. W diagnostyce uzupełniającej stosuje się testy molekularne, takie jak DermTech Melanoma (negatywna wartość predykcyjna >99%), panele ekspresji genów oraz badania mutacji BRAF, NRAS i KIT, co pozwala na precyzyjne określenie charakterystyki guza i planowanie terapii celowanej. Histopatologia ocenia także owrzodzenie, wskaźnik mitotyczny, naciekanie naczyń i obecność nacieku limfocytarnego, co wpływa na klasyfikację TNM i rokowanie.

Diagnoza czerniaka – wprowadzenie

Czerniak (melanoma) jest jednym z najgroźniejszych typów nowotworów skóry. Stanowi około 1% wszystkich nowotworów skóry, ale odpowiada za zdecydowaną większość zgonów spowodowanych nowotworami skórnymi. Wczesne wykrycie i dokładna diagnoza czerniaka mają kluczowe znaczenie dla skutecznego leczenia i poprawy rokowania pacjenta. Diagnoza czerniaka opiera się na kompleksowym podejściu, które obejmuje badanie kliniczne, metody diagnostyki obrazowej oraz analizę histopatologiczną.12

Według Amerykańskiego Towarzystwa Onkologicznego, w 2025 roku w Stanach Zjednoczonych zostanie zdiagnozowanych około 104 960 nowych przypadków czerniaka, a około 8 430 pacjentów umrze z powodu tego nowotworu. Czerniak jest diagnozowany średnio w wieku 66 lat, jednak nie jest rzadkością u osób poniżej 30. roku życia. Jest to faktycznie jeden z najczęstszych nowotworów występujących u młodych dorosłych, szczególnie u młodych kobiet.12

Badanie kliniczne i wstępna ocena

Proces diagnostyczny czerniaka zwykle rozpoczyna się od dokładnego badania klinicznego przeprowadzonego przez lekarza. Podczas badania lekarz zbiera szczegółowy wywiad medyczny, ocenia czynniki ryzyka oraz przeprowadza dokładne badanie skóry. Kluczowe informacje, które powinny zostać uzyskane podczas wywiadu, to:12

  • Historia ekspozycji na promieniowanie UV
  • Występowanie czerniaka lub innych nowotworów skóry w wywiadzie rodzinnym
  • Wcześniejsze zmiany skórne lub znamiona
  • Kiedy podejrzana zmiana została zauważona
  • Czy zmiana ulegała ewolucji (zmiana rozmiaru, kształtu, koloru)
  • Obecność objawów takich jak krwawienie, świąd, owrzodzenie

12

Badanie fizykalne koncentruje się na ocenie podejrzanych zmian skórnych z wykorzystaniem kryteriów ABCDE:12

  • A (asymmetry) – asymetria zmiany
  • B (border) – nieregularne, postrzępione brzegi
  • C (color) – niejednorodne zabarwienie
  • D (diameter) – średnica zwykle większa niż 6 mm
  • E (evolving) – zmiana ewoluująca w czasie

12

Dodatkowe kryterium „objaw brzydkiego kaczątka” (ugly duckling sign) odnosi się do zmiany skórnej, która wyraźnie różni się od innych znamion na skórze pacjenta. Podczas badania lekarz może również ocenić okoliczne węzły chłonne pod kątem powiększenia, co może sugerować rozsiew nowotworu.12

Techniki wspomagające badanie kliniczne

Dla zwiększenia dokładności diagnozy, lekarze często wykorzystują dodatkowe narzędzia diagnostyczne:12

  • Dermatoskopia – badanie skóry przy użyciu dermatoskopu (ręcznego urządzenia z wbudowanym oświetleniem i lupą), które umożliwia wizualizację struktur skóry niewidocznych gołym okiem. Technika ta znacznie zwiększa dokładność diagnostyczną w porównaniu do samego badania wzrokowego.
  • Mikroskopia konfokalna refleksyjna – nieinwazyjna technika obrazowania, która umożliwia wizualizację skóry na poziomie komórkowym bez konieczności wykonywania biopsji.
  • Optyczna tomografia koherencyjna (OCT) – technika wykorzystująca laser podczerwony o niskiej mocy do obrazowania zmian poniżej powierzchni skóry.
  • Całościowa fotografia ciała (total body photography) – umożliwia dokumentację i monitorowanie zmian skórnych na całym ciele, szczególnie przydatna dla pacjentów z licznymi znamionami.

123

Biopsja – złoty standard diagnozy

Biopsja jest jedyną metodą, która pozwala na definitywne potwierdzenie diagnozy czerniaka. Polega na pobraniu próbki tkanki z podejrzanej zmiany, która następnie jest badana mikroskopowo przez patomorfologa. Istnieje kilka typów biopsji stosowanych w diagnostyce czerniaka:123

Rodzaje biopsji

  • Biopsja wycinająca (excisional biopsy) – usunięcie całej podejrzanej zmiany wraz z marginesem zdrowej skóry (około 1-3 mm). Jest to preferowana metoda diagnostyczna, ponieważ umożliwia pełną ocenę grubości czerniaka (głębokości inwazji), co ma kluczowe znaczenie dla ustalenia stadium zaawansowania i rokowania.
  • Biopsja ścinająca (shave biopsy) – usuwa najbardziej wypukłą część zmiany. Nie jest zalecana przy podejrzeniu czerniaka, ponieważ może nie obejmować całej głębokości zmiany, co utrudnia określenie grubości guza.
  • Biopsja stemplowa (punch biopsy) – wykorzystuje okrągłe narzędzie tnące do pobrania głębszych warstw skóry. Może być stosowana do diagnostyki większych zmian, gdy biopsja wycinająca nie jest możliwa.
  • Biopsja nacinająca (incisional biopsy) – polega na wycięciu tylko części podejrzanej zmiany. Stosowana rzadziej, głównie gdy zmiana jest zbyt duża lub znajduje się w trudnej do całkowitego wycięcia lokalizacji.

1234

Biopsja wycinająca jest metodą z wyboru, ponieważ umożliwia dokładną ocenę głębokości inwazji czerniaka (grubość według Breslowa), co ma kluczowe znaczenie dla określenia rokowania i planowania dalszego leczenia. Pobrany materiał jest następnie badany przez patomorfologa, który potwierdza diagnozę czerniaka i określa jego cechy histologiczne.123

Nowe metody diagnostyczne

W ostatnich latach pojawiły się nieinwazyjne lub minimalnie inwazyjne metody diagnostyczne, które mogą uzupełniać lub poprzedzać tradycyjną biopsję:12

  • Test DermTech Melanoma (DMT) – nieinwazyjna metoda, która wykorzystuje specjalną taśmę do pobrania komórek z powierzchni skóry. Następnie próbka jest analizowana pod kątem obecności markerów genetycznych związanych z czerniakiem. Test ten ma wysoką negatywną wartość predykcyjną (ponad 99%), co oznacza, że jeśli wynik testu jest negatywny, prawdopodobieństwo czerniaka jest bardzo niskie.
  • Panel ekspresji genów (GEP) – technika analizująca profil ekspresji genów w komórkach czerniaka, która może pomóc patomorfologom w określeniu, czy zmiana jest łagodna czy złośliwa.
  • Test myPath Melanoma – analizuje ekspresję 23 genów i dostarcza pojedynczy wynik liczbowy, który klasyfikuje zmiany skórne jako prawdopodobnie łagodne, prawdopodobnie złośliwe lub nieokreślone.

1234

Ocena histopatologiczna i kluczowe parametry

Analiza histopatologiczna jest niezbędna do potwierdzenia diagnozy czerniaka i określenia jego charakterystyki. Patomorfolog ocenia mikroskopowo pobraną tkankę i analizuje szereg cech, które mają znaczenie diagnostyczne, prognostyczne i terapeutyczne.12

Kluczowe parametry histopatologiczne

  • Grubość Breslowa – najważniejszy czynnik prognostyczny, mierzony w milimetrach od warstwy ziarnistej naskórka do najgłębszej części nowotworu. Im większa grubość, tym gorsze rokowanie.
  • Poziom Clarka – określa głębokość inwazji czerniaka w odniesieniu do warstw anatomicznych skóry (od I do V). Chociaż nadal bywa raportowany, ma mniejsze znaczenie prognostyczne niż grubość Breslowa.
  • Owrzodzenie – obecność przerwania ciągłości naskórka nad czerniakiem jest negatywnym czynnikiem prognostycznym i wpływa na klasyfikację TNM.
  • Wskaźnik mitotyczny – liczba podziałów komórkowych (mitoz) na mm². Wysoki wskaźnik mitotyczny wskazuje na szybki wzrost nowotworu i gorsze rokowanie.
  • Regresja – częściowe zanikanie komórek czerniaka zastępowanych przez włóknienie i naciek zapalny.
  • Naciekanie naczyń limfatycznych i krwionośnych – obecność komórek nowotworowych w naczyniach wskazuje na zwiększone ryzyko przerzutów.
  • Naciek limfocytarny (TILs) – obecność limfocytów naciekających guz, co może wskazywać na odpowiedź immunologiczną organizmu na nowotwór.

1234

Badania molekularne i immunohistochemiczne

Coraz częściej w diagnostyce czerniaka wykorzystuje się zaawansowane techniki molekularne i immunohistochemiczne:12

  • Fluorescencyjna hybrydyzacja in situ (FISH) – technika umożliwiająca identyfikację specyficznych sekwencji DNA w komórkach czerniaka.
  • Porównawcza hybrydyzacja genomowa (CGH) – metoda wykrywająca zmiany w liczbie kopii DNA, co może pomóc w diagnozie trudnych przypadków, takich jak czerniak nevoidalny i czerniak spitzoidalny.
  • Badania mutacji genowych – analiza obecności mutacji w genach takich jak BRAF, NRAS i KIT. Szczególnie ważna jest identyfikacja mutacji BRAF (występującej w około 50% przypadków czerniaka), która może umożliwić zastosowanie terapii celowanej inhibitorami BRAF u pacjentów z zaawansowaną chorobą.
  • Sekwencjonowanie genomu – kompleksowa analiza materiału genetycznego nowotworu, np. przy użyciu testu MSK-IMPACT, który bada mutacje w ponad 450 genach jednocześnie.

1234

Ocena zaawansowania i staging czerniaka

Po potwierdzeniu diagnozy czerniaka, kolejnym kluczowym krokiem jest określenie stadium zaawansowania choroby (staging), co ma fundamentalne znaczenie dla planowania leczenia i oceny rokowania. Najbardziej powszechnie stosowanym systemem klasyfikacji jest system TNM opracowany przez American Joint Committee on Cancer (AJCC).12

System TNM i stadia czerniaka

System TNM uwzględnia trzy główne czynniki:12

  • T (tumor) – ocenia pierwotny guz, głównie jego grubość (Breslowa) i obecność owrzodzenia
  • N (nodes) – określa zajęcie regionalnych węzłów chłonnych
  • M (metastasis) – ocenia obecność przerzutów odległych

12

Na podstawie klasyfikacji TNM wyróżnia się następujące stadia czerniaka:123

  • Stadium 0 (in situ) – czerniak ograniczony do naskórka, nie naciekający skóry właściwej
  • Stadium I – wczesny, zlokalizowany czerniak o grubości do 2 mm, bez zajęcia węzłów chłonnych
  • Stadium II – czerniak o grubości powyżej 2 mm lub czerniak z owrzodzeniem, bez zajęcia węzłów chłonnych
  • Stadium III – czerniak z przerzutami do regionalnych węzłów chłonnych lub z satelitozą/przerzutami in-transit
  • Stadium IV – czerniak z przerzutami odległymi (np. do płuc, wątroby, mózgu, kości)

123

Stadium czerniaka ma kluczowe znaczenie dla rokowania. Pięcioletnie wskaźniki przeżycia wynoszą około 99% dla czerniaka w stadium I, ale znacznie spadają w stadiach bardziej zaawansowanych. Dla stadiów III i IV wskaźniki te wynoszą odpowiednio około 75% i 35%, co stanowi poprawę w porównaniu do wcześniejszych lat, dzięki wprowadzeniu nowoczesnych metod leczenia, takich jak immunoterapia i terapia celowana.12

Badania dodatkowe w określaniu stadium zaawansowania

W zależności od wstępnej oceny grubości czerniaka i innych cech klinicznych, mogą być zalecane dodatkowe badania w celu określenia stadium zaawansowania:12

  • Biopsja węzła wartowniczego (SLNB) – procedura chirurgiczna polegająca na identyfikacji i usunięciu pierwszego węzła chłonnego, do którego spływa chłonka z obszaru czerniaka. Węzeł ten jest następnie badany pod kątem obecności komórek nowotworowych. SLNB jest zazwyczaj zalecana dla czerniaków o grubości powyżej 0,8 mm lub przy obecności innych niekorzystnych czynników prognostycznych.
  • Biopsja cienkoigłowa (FNA) – może być wykonana w przypadku klinicznie podejrzanych węzłów chłonnych w celu potwierdzenia obecności przerzutów.
  • Badania obrazowe – w zależności od stadium i cech klinicznych czerniaka mogą być zalecane:
    • Ultrasonografia – szczególnie przydatna do oceny regionalnych węzłów chłonnych
    • Tomografia komputerowa (CT) – ocena potencjalnych przerzutów do narządów wewnętrznych
    • Rezonans magnetyczny (MRI) – szczególnie przydatny do oceny potencjalnych przerzutów do mózgu
    • Pozytonowa tomografia emisyjna (PET) lub PET-CT – umożliwia wykrycie aktywnych metabolicznie ognisk nowotworowych w całym ciele
  • Badania laboratoryjne – ocena markerów biochemicznych, takich jak dehydrogenaza mleczanowa (LDH), której podwyższony poziom może wskazywać na zaawansowaną chorobę.

1234

Wyzwania diagnostyczne w czerniaku

Mimo znacznego postępu w diagnostyce czerniaka, pewne przypadki nadal stanowią wyzwanie diagnostyczne:12

  • Czerniak amelanotyczny – rzadki wariant czerniaka, który nie produkuje melaniny i może być trudny do rozpoznania ze względu na brak charakterystycznego zabarwienia.
  • Czerniak nevoidalny i spitzoidalny – te podtypy mogą przypominać łagodne znamiona pod mikroskopem, co utrudnia diagnozę.
  • Czerniak desmoplastyczny – rzadki podtyp czerniaka z obfitym podścieliskiem włóknistym, często bez typowych cech czerniaka.
  • Czerniak o nieznanym ognisku pierwotnym – w 3-5% przypadków diagnozuje się przerzuty czerniaka bez możliwości identyfikacji pierwotnego guza skórnego.

12

W tych trudnych przypadkach szczególnie przydatne mogą być zaawansowane techniki diagnostyczne, takie jak badania immunohistochemiczne, molekularne i genetyczne, które mogą pomóc w postawieniu właściwej diagnozy.123

Znaczenie wczesnej i dokładnej diagnozy

Wczesna i dokładna diagnoza czerniaka ma fundamentalne znaczenie dla rokowania pacjenta:12

  • Czerniak wykryty we wczesnym stadium (0 lub I) ma wskaźnik pięcioletniego przeżycia bliski 100%.
  • Wraz z postępem choroby wskaźniki przeżycia znacząco spadają – dla stadium IV (z przerzutami odległymi) wskaźnik pięcioletniego przeżycia wynosi około 35%.
  • Czerniak może rozprzestrzeniać się bardzo szybko – w ciągu zaledwie 6 tygodni od wystąpienia może stać się zagrażający życiu, jeśli nie zostanie leczony.
  • Dokładna diagnoza umożliwia wybór optymalnej metody leczenia, co może znacząco wpłynąć na wynik terapii.

123

Według najnowszych danych, wskaźniki śmiertelności z powodu czerniaka znacząco spadły w latach 2013-2022, głównie dzięki postępom w leczeniu, w tym wprowadzeniu nowoczesnych terapii takich jak immunoterapia i terapia celowana.12

Postępowanie po diagnozie czerniaka

Po postawieniu diagnozy czerniaka, dalsze postępowanie zależy głównie od stadium zaawansowania choroby:12

  • Stadium 0-I – zwykle wystarczającym leczeniem jest szerokie wycięcie chirurgiczne zmiany (wide local excision) z odpowiednim marginesem zdrowej skóry (zwykle 5-10 mm).
  • Stadium II – podstawowym leczeniem jest szerokie wycięcie chirurgiczne, często uzupełnione o biopsję węzła wartowniczego. W zależności od czynników ryzyka może być rozważana terapia uzupełniająca.
  • Stadium III – leczenie jest bardziej złożone i może obejmować szerokie wycięcie miejscowe, biopsję węzła wartowniczego, limfadenektomię (usunięcie zajętych węzłów chłonnych) oraz terapię uzupełniającą (adjuwantową).
  • Stadium IV – leczenie opiera się głównie na terapii systemowej, w tym immunoterapii (np. pembrolizumab, nivolumab, ipilimumab), terapii celowanej (inhibitory BRAF i MEK u pacjentów z mutacją BRAF) oraz, rzadziej, chemioterapii.

1234

Po zakończeniu leczenia pacjenci wymagają regularnej obserwacji (follow-up), gdyż czerniak może nawrócić nawet po wielu latach. Zalecane są regularne badania skóry, badania obrazowe oraz samokontrola, której częstotliwość zależy od stadium choroby i czynników ryzyka.12

Znaczenie diagnostyki w leczeniu czerniaka

Diagnoza czerniaka jest procesem wieloetapowym, wymagającym współpracy specjalistów z różnych dziedzin, w tym dermatologów, chirurgów, patomorfologów i onkologów. Wczesne wykrycie i dokładna diagnoza są kluczowe dla skutecznego leczenia i poprawy rokowania pacjentów.12

Znaczny postęp w diagnostyce czerniaka, w tym wprowadzenie zaawansowanych technik obrazowania, badań molekularnych i genetycznych, przyczynia się do coraz dokładniejszej oceny choroby, co umożliwia personalizację leczenia i poprawę wyników terapeutycznych. Jednocześnie, profilaktyka i regularne badania skóry pozostają kluczowymi elementami w walce z czerniakiem.123

Kolejne rozdziały

Zapraszamy do dalszego czytania naszego leksykonu.

Wybierz kolejny rozdział z menu poniżej, aby otworzyć nową podstronę kompedium wiedzy i uzyskać szczegółowe informację o leku, substancji lub chorobie.

  1. 10.04.2026
  2. www.leksykon.com.pl

Materiały źródłowe

  • #1 Melanoma Skin Cancer Statistics | American Cancer Society
    https://www.cancer.org/cancer/types/melanoma-skin-cancer/about/key-statistics.html
    Melanoma accounts for only about 1% of skin cancers but causes a large majority of skin cancer deaths. […] The American Cancer Societys estimates for melanoma in the United States for 2025 are: About 104,960 new melanomas will be diagnosed (about 60,550 in men and 44,410 in women). […] Melanoma death rates declined rapidly from 2013 to 2022, largely because of advances in treatment. […] The average age of people when it is diagnosed is 66. But melanoma is not uncommon even among those younger than 30. In fact, its one of the most common cancers in young adults (especially young women). […] For survival statistics, see Survival Rates for Melanoma Skin Cancer by Stage. […] Early Detection, Diagnosis, and Staging
  • #1 Tests For Melanoma Skin Cancer | Melanoma Diagnosis | American Cancer Society
    https://www.cancer.org/cancer/types/melanoma-skin-cancer/detection-diagnosis-staging/how-diagnosed.html
    Most melanomas are brought to a doctors attention because of signs or symptoms a person is having. […] If you have an abnormal area on your skin that might be cancer, your doctor will examine it and might do tests to find out if it is melanoma, another type of skin cancer, or some other skin condition. […] If melanoma is found, other tests might then be done to learn more about it, such as if it has spread to other areas of the body. […] The first step your doctor usually takes is to ask about your symptoms, such as when the mark on the skin first appeared, if it has changed in size or appearance, and if it has been painful, itchy, or bleeding. […] During the physical exam, your doctor will note the size, shape, color, and texture of the area(s) in question, and whether it is bleeding, oozing, or crusting.
  • #1 Melanoma Diagnosis | Memorial Sloan Kettering Cancer Center
    https://www.mskcc.org/cancer-care/types/melanoma/diagnosis
    Melanoma Diagnosis […] To determine whether you have melanoma, your doctor will take a complete medical history and ask for details about: […] your past exposure to the sun […] whether you have any personal or family history of melanoma […] when you first noticed the spot […] if the spot has changed at all in size or appearance […] Your doctor will also do a skin examination and check for enlarged lymph nodes. […] If your doctor thinks that a particular spot on your skin may be melanoma, youll most likely need to have a biopsy. In this test, a doctor removes a small piece of tissue. A pathologist (a doctor who specializes in diagnosing disease) will examine the tissue under a microscope to determine whether melanoma cells are present. […] Your care team will also need to diagnose which type of melanoma you have and determine how extensive it is. This is a key first step in developing the best treatment plan for you.
  • #1 Melanoma: Diagnosis
    https://healthlibrary.uwmedicine.org/Conditions/Cancer/Tools/Quizzes/85,P01354
    If your healthcare provider thinks you might have melanoma, you will likely need certain exams and tests to be sure. Diagnosing melanoma starts with your healthcare provider asking you questions. They will ask you about your health history, your symptoms, risk factors, and family history of disease. Your healthcare provider will also examine you. They will take a close look at any suspicious moles or other marks on your skin. Your healthcare provider will look at your skin with the ABCDE rule in mind. This means looking at: […] A biopsy is taking a sample of tissue that will be examined in a lab. This is needed to confirm if a suspicious mole or spot is melanoma. Your healthcare provider will likely take a biopsy of any mole or other skin mark that may look like cancer. […] A biopsy sample is sent to a lab, where a healthcare provider called a pathologist examines them under a microscope. They may do other tests on them to see if they contain melanoma cells.
  • #1 Cancer Society NZ — Diagnosing melanoma skin cancer
    https://www.cancer.org.nz/cancer/types-of-cancer/melanoma-of-the-skin/diagnosing-melanoma-skin-cancer/
    Most of us have spots on our skin. It’s important to notice any changes in the size, shape, and/or colour of your spots or moles. […] If you see a new spot or a change in an existing spot or mole, it needs to be checked by your doctor or a skin specialist. Your doctor checks the spots that have changed and do a general check of your skin. They will use a handheld magnifying tool called a dermatoscope to look at the spot or mole and judge it by the “ABCDE” criteria: Asymmetry The spot has an irregular shape. Border The spot has uneven or scalloped edges. Colour The spot has different shades and colour patches. Diameter The spot is usually over 6mm wide across. Evolving The spot is changing and growing. […] Your doctor will also ask if you or anyone in your family/whānau have had a melanoma or other skin cancer before. They may also feel the lymph nodes (glands) in the area nearest your spot or mole to check if they are swollen.
  • #1 Melanoma Skin Cancer: Images, Diagnosis, and Treatment — DermNet
    https://dermnetnz.org/topics/melanoma
    Melanoma may be suspected because of a lesion’s clinical features or a history of change. […] A thorough history and skin examination will be performed using the „ugly duckling” sign, ABCDE rule, and the Glasgow revised seven-point checklist (described above). This may be supported by dermoscopy, confocal microscopy, total body photography (mole mapping), and adhesive patch genomic analysis, among other methods. […] Histopathology is required for the definitive diagnosis of melanoma. […] The pathological diagnosis of melanoma can be very difficult. […] The report may also include comments about the cell type, growth pattern, invasion of blood vessels or nerves, inflammatory response, regression, associated in-situ disease and any associated naevus (original mole). […] Melanoma staging means finding out if the melanoma has spread from its original site in the skin.
  • #1 Melanoma Diagnosis | Memorial Sloan Kettering Cancer Center
    https://www.mskcc.org/cancer-care/types/melanoma/diagnosis
    A biopsy is often the first step in diagnosing skin melanoma. During a biopsy, a doctor removes a small amount of tissue from the area where the cancer is suspected. The sample is sent to a pathologist, who examines it under a microscope and works with the other members of the care team to make a diagnosis. […] At MSK, we have a team of pathologists whose sole focus is diagnosing skin cancer, such as melanoma. This specialization allows them to make the most precise diagnosis possible. A more precise diagnosis can improve the effectiveness of your treatment or spare you from treatment that wont work against the disease. […] There are also several noninvasive techniques that doctors can use to evaluate possible melanomas. Dermoscopy is one common approach. It involves the use of a handheld device called a dermatoscope. This tool gives doctors a close-up view of the skin using a powerful microscope and special light.
  • #1 Melanoma Diagnosis | Memorial Sloan Kettering Cancer Center
    https://www.mskcc.org/cancer-care/types/melanoma/diagnosis
    MSK also offers a sophisticated new approach developed by our experts called reflectance confocal microscopy. It uses a low-power laser to provide real-time images of a tumor. […] With confocal microscopy, doctors can map melanoma and other skin cancers in precise detail. It can be an especially powerful tool when the borders of a melanoma are difficult to distinguish. MSK doctors may use it when the borders of a tumor are vague or when conventional imaging cant pick up the differences between cancerous tissue and sun-damaged tissue. […] Molecular tests, such as fluorescence in situ hybridization (FISH) and comparative genomic hybridization (CGH), can be used to analyze the DNA of suspicious spots on the skin to help make difficult diagnoses. They are especially useful for diagnosing nevoid melanoma and spitzoid melanoma, which may look like benign skin moles under a microscope. These tests are readily available at MSK.
  • #1 Melanoma – Diagnosis and treatment – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/melanoma/diagnosis-treatment/drc-20374888
    Excisional biopsy of the skin […] During an excisional biopsy, a scalpel is used to cut out a lump or an area of irregular skin and some surrounding healthy skin. As a rule, stitches are needed to close the wound. […] During a punch biopsy, a round-tipped cutting tool is used to remove deeper layers of skin for testing. Depending on the size, stitches may be needed to close the wound. […] Tests and procedures used to diagnose melanoma include: […] Your healthcare professional will ask questions about your health history. That person also will examine your skin to look for signs that could mean melanoma. […] A biopsy is a procedure to remove a sample of tissue for testing in a lab. What type of biopsy procedure is used depends on your situation. Most often healthcare professionals recommend removing the entire growth when possible.
  • #1 Current state of melanoma diagnosis and treatment
    https://pmc.ncbi.nlm.nih.gov/articles/PMC6804807/
    Melanoma is the deadliest form of skin cancer. In the early stages, melanoma can be treated successfully with surgery alone and survival rates are high, but after metastasis survival rates drop significantly. Therefore, early and correct diagnosis is key for ensuring patients have the best possible prognosis. Melanoma misdiagnosis accounts for more pathology and dermatology malpractice claims than any cancer other than breast cancer, as an early misdiagnosis can significantly reduce a patients chances of survival. […] Thus, new biomarkers and drug targets are needed to improve the accuracy of melanoma diagnosis and treatment. […] The early classification of melanoma was based on where the tumor arose from (existing nevus, acquired melanocytic lesion, blemish free skin), but in the 1960s a prominent dermatologist, Wallace Clark, suggested that melanoma ought to be classified based on histological features instead, thus revolutionizing the way melanoma was diagnosed.
  • #1 Confirming Your Diagnosis of Melanoma Skin Cancer – MRA
    https://www.curemelanoma.org/patient-eng/diagnosing-melanoma/confirming-the-diagnosis
    After identifying a suspect lesion, your doctor may suggest either removing it outright or further testing. Further testing is sometimes suggested because even after careful examination, it is not always clear if a suspicious mole or lesion is cancerous. […] The gold standard for determining if a suspicious mole is cancerous is a biopsy with thorough pathological examination. However, biopsies are not always needed or ideal and may not be appropriate due to the associated scarring, costs, or the presence of preexisting conditions that make healing more difficult. […] This is especially true for sensitive areas, such as the face or ears. […] Despite being the gold standard for diagnosing melanoma, it is not a perfect tool. […] Due to these concerns, many doctors are turning to non-invasive techniques that can give them more information instead of or before a traditional biopsy.
  • #1 Confirming Your Diagnosis of Melanoma Skin Cancer – MRA
    https://www.curemelanoma.org/patient-eng/diagnosing-melanoma/confirming-the-diagnosis
    One example of a non-invasive test that can help doctors and patients decide whether to biopsy a suspicious skin lesion is the DermTech Melanoma Test (DMT). […] The DermTech Melanoma Test has a negative predictive value exceeding 99%, which means that over 99% of lesions that contain no melanoma-associated markers using the test are truly negative for melanoma. […] Since a biopsy is the gold standard for making a melanoma diagnosis, your doctor may suggest a biopsy regardless of your non-invasive testing result. […] A skin biopsy is a minor medical procedure performed on a suspicious spot to retrieve a sample of cells, which will then be carefully examined under a microscope by an expert called a pathologist. […] The pathologist will test cells from your biopsy sample and provide you and your doctor with a comprehensive report based on their findings.
  • #1 Current state of melanoma diagnosis and treatment
    https://pmc.ncbi.nlm.nih.gov/articles/PMC6804807/
    Furthermore, in 1966 Clark proposed a system for evaluating melanoma based the depth of invasion of melanoma cells into the dermis and subcutaneous fat. […] The Clark levels still remain a standardized way to convey information related to risk of disease aggressiveness and are reported in melanoma reports by some pathologists, however in 1970 Alexander Breslow independently devised a more accurate method for classifying melanoma based on a measured depth of invasion that captured the thickness of the tumor. […] The most recent revision of the AJCC staging manual (8th edition) was released in 2016 and implemented in 2018. […] Staging is vitally important as it gives clinicians the tools to assess patient prognosis and put together a treatment regimen that will give the patient the best possible chance for recovery or prolonged survival.
  • #1 Understanding Your Melanoma Diagnosis & Pathology Report – Melanoma Research Alliance
    https://www.curemelanoma.org/patient-eng/ten-tips-for-people-just-diagnosed-with-melanoma/get-educated
    If the diagnosis is a melanoma, the information in your pathology report will describe the type of melanoma and certain features that help assess how aggressive it is such as tumor thickness and whether its ulcerated or not. […] These features are used by the pathologist to stage the tumor. This pathology staging considers only the tumor itself and is different from the clinical staging, which involves looking whether or not the tumor has spread elsewhere in your body. […] The report may describe the type of melanoma as cutaneous, acral, mucosal, uveal, desmoplastic, or nevoid melanoma (or Merkel cell carcinoma), depending upon features examined and the area of the body where the skin lesion resides. […] Histologic types: The most common type of melanoma is cutaneous melanoma. Histologic types of cutaneous melanoma are superficial spreading (accounting for 70% of cases), nodular (accounting for 20% of cases), lentigo maligna, acral lentiginous, and desmoplastic.
  • #1 Current state of melanoma diagnosis and treatment
    https://pmc.ncbi.nlm.nih.gov/articles/PMC6804807/
    However, it has long been observed that, though there is an international staging system, the diagnosis of melanoma remains a difficult one to render accurately and consistently. […] To improve detection and diagnosis of melanoma (as well as other cancers), non-invasive imaging technology pre-biopsy and more quantitative techniques post-biopsy, such as fluorescence in situ hybridization (FISH), comparative genomic hybridization (CGH), sequencing, mass spectrometry (MS) and IHC are being used more frequently. […] Regardless of the detection method, diagnosis of melanoma requires that a lesion be recognized as clinically atypical and biopsied by a health care provider. […] Melanoma is generally diagnosed by trained pathologists based on a variety of classic histopathological features. […] The use of IHC has even become important in staging systems.
  • #1 Understanding Your Melanoma Diagnosis & Pathology Report – Melanoma Research Alliance
    https://www.curemelanoma.org/patient-eng/ten-tips-for-people-just-diagnosed-with-melanoma/get-educated
    Lymphovascular invasion: The presence of tumor cells in blood vessels or lymphatic vessels. Options are present or absent. […] If you have metastatic melanoma (stage 4; melanoma that has spread), it is vital to have a biopsy of your metastatic tumor and appropriate comprehensive biomarker testing (example: genomic testing), as well as all other appropriate tests recommended by your doctor as early as possible to help determine your best treatment options. […] If you have stage 3 or 4 melanoma, you will likely be tested for mutations in genes named BRAF, NRAS, and KIT. The results will help you and your doctor make treatment decisions because drugs have been developed that specifically target cancer cells with these mutations.
  • #1 Melanoma – Diagnosis and treatment – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/melanoma/diagnosis-treatment/drc-20374888
    Your healthcare team uses the results from these tests to figure out your melanoma’s stage. Melanoma stages use the numbers 0 through 4. At stage 0 and stage 1, a melanoma is thin and small. Treatment is likely to be successful. As the melanoma grows deeper into the skin, the stages get higher. Treatment becomes more challenging. By stage 4, the cancer has spread beyond the skin to other organs, such as the lungs or liver.
  • #1 Melanoma Diagnosis and Staging | Melanoma | UT Southwestern Medical Center
    https://utswmed.org/conditions-treatments/melanoma/melanoma-diagnosis-and-staging/
    How Is Melanoma Staged? […] Our physicians determine a melanomas stage the severity and extent to which it has metastasized beyond the primary location by considering these factors: […] The location(s) of the disease […] The thickness and other features of the primary melanoma tumor […] Whether and to what extent melanoma cells have spread to the lymph nodes or other parts of the body […] The results of a lactate dehydrogenase (LDH) blood test […] What Are the Stages of Melanoma? […] There are five stages of melanoma: […] Stage 0 (in situ): Pre-melanoma that has the potential to become melanoma […] Stage I: Early, localized disease with no melanoma in the lymph nodes […] Stage II: Fairly early, fairly localized disease that is slightly more advanced than Stage I, with no melanoma in the lymph nodes […] Stage III: Disease that has spread to areas in the skin near the primary location or the lymph nodes near the melanoma […] Stage IV (metastatic): Disease that has spread via the lymph nodes or the bloodstream to distant parts of the body most commonly the lungs, liver, bones, and brain.
  • #1 Melanoma Stages 0, 1, 2, 3 and 4 Metastatic | Memorial Sloan Kettering Cancer Center
    https://www.mskcc.org/cancer-care/types/melanoma/diagnosis/melanoma-stages
    MSK melanoma staging expert Allan Halpern is smiling at the camera. […] Staging is part of the diagnosis process. It tells you how advanced the melanoma is or whether it has spread. Staging also helps your doctor decide how to move forward with treatment and follow-up care. […] Your doctor will give you a physical exam and review the results of your diagnostic and imaging tests. Then they will decide the stage of the cancer. They may adjust the stage if you have surgery or more tests. […] There are 5 stages of melanoma, from 0 to 4. The lower the number, the less the cancer has spread. We also break down some stages even more, into stages A, B, C, and D. […] Invasive melanoma is cancer that can spread to other areas of the body. Melanoma is divided into stages based on the thickness of the primary tumor and other features. The thickness of a tumor is the most important risk factor. The thicker the tumor, the more likely it will spread.
  • #1 Diagnosis & Tests for Melanoma
    https://www.texasoncology.com/types-of-cancer/melanoma/diagnosis-tests-for-melanoma
    Doctors need to determine the stage or the extent of the spread of the cancer. A cancers stage is a key factor in determining the best treatment. […] Patients with stage I malignant melanoma have cancer that is found in the outer layer of the skin (epidermis) and/or the upper part of the inner layer of skin (dermis) but has not spread to lymph nodes. […] Stage III melanoma includes cancers of any thickness that have spread to the regional lymph nodes. The extent or amount of tumor in the lymph nodes is the most important prognostic factor for patients with stage III melanoma. […] Patients with stage IV, or metastatic, melanoma have cancer that has spread from its site of origin to distant lymph nodes or other distant sites in the body, such as the liver, lungs, or brain.
  • #1 Melanoma: Diagnosis and Treatment | AAFP
    https://www.aafp.org/pubs/afp/issues/2024/1000/melanoma.html
    Thin lesions with a Breslow depth of less than 0.8 mm usually do not need further treatment after wide local excision and have an excellent prognosis. Lesions with a Breslow depth greater than 0.8 mm may need further diagnostic tests or procedures, including sentinel lymph node biopsy, complete lymph node dissection, gene mutation analysis, and possible treatment with systemic immunotherapy. Use of systemic immunotherapies has improved the prognosis for advanced melanoma (stages III and IV), with 5-year survival rates of 74.8% and 35%, respectively, compared with 62.6% and 16% from 1975 to 2011 before immunotherapy was available.
  • #1 Melanoma – Diagnosis and treatment – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/melanoma/diagnosis-treatment/drc-20374888
    Thinner melanomas may only require surgery to remove the cancer and some healthy tissue around it. If the melanoma is thicker, your healthcare team may recommend more tests to see if the cancer has spread before deciding on your treatment options. […] See if the melanoma has spread to the lymph nodes. If there’s a risk that the cancer has spread to nearby lymph nodes, you might need a sentinel node biopsy. […] During a sentinel node biopsy, a dye is injected in the area where your melanoma was removed. The dye flows to the nearby lymph nodes. The first lymph nodes to take up the dye are removed and tested for cancer cells. […] Look for signs of cancer beyond the skin. If there is concern that the melanoma has spread, imaging tests might be used to look for signs of cancer in other areas of the body.
  • #1 Understanding Your Pathology Report: Melanoma | OncoLink
    https://www.oncolink.org/cancers/skin/melanoma/treatments/understanding-your-pathology-report-melanoma
    A high LDH can mean metastasis and is used in staging melanoma. […] Testing for a BRAF mutation is often done in patients with advanced or aggressive melanoma to see if these BRAF Inhibitor therapies are a treatment option. […] Staging helps group cancers based on the size and extent of the tumor and helps guide your treatment. Different staging systems are used for each type of cancer. The staging system most often used for melanoma is the American Joint Committee on Cancer (AJCC) staging system.
  • #1 Cutaneous Diagnosis – Melanoma Research Foundation
    https://melanoma.org/cutaneous-melanoma/cutaneous-diagnosis/
    Diagnosing melanoma can be a difficult task, even for a trained dermatologist or physician. […] A biopsy and examination of the tissue under the microscope is the only way melanoma of the skin can be diagnosed. […] A pathologist (or dermatopathologist) will analyze the biopsy under a microscope. By looking at and testing the tissue, the pathologist will find out if the tissue is cancerous or not cancerous. A cancerous tumor is malignant, which means it can spread to other parts of the body. A noncancerous (benign) tumor means the tumor may grow but it will not spread to other parts of the body. […] Based on what the pathologist sees under the microscope, he or she will then write a pathology report. A pathology report is a medical document that gives a diagnosis based on the examination of the biopsy.
  • #1 LCD – MolDX: Molecular Assays for the Diagnosis of Cutaneous Melanoma (L39389)
    https://www.cms.gov/medicare-coverage-database/view/lcd.aspx?lcdid=39389&ver=3
    This LCd outlines limited coverage for this service with specific details under Coverage Indications, Limitations and/or Medical Necessity. […] The purpose of this test is to assist dermatopathologists to arrive at the correct diagnosis of melanoma versus non-melanoma when examining skin biopsies. […] This Medicare contractor will provide limited coverage for molecular Deoxyribonucleic acid (DNA)/Ribonucleic acid (RNA) assays that aid in the diagnosis or exclusion of melanoma from a biopsy when ALL of the following clinical conditions are met: […] Many melanomas are curable if detected early and diagnosed accurately. […] Melanoma can be difficult to diagnose, particularly in its earliest stages, yet accurate diagnosis of melanocytic neoplasms is vital to optimal patient outcomes. […] Histopathologic examination has long been the gold standard for melanoma diagnosis, and while it is adequate for most cases, evidence suggests that approximately 15-20% of all biopsied melanocytic neoplasms are difficult to diagnose by histopathology alone.
  • #1 Melanoma: Clinical features and diagnosis – UpToDate
    https://www.uptodate.com/contents/melanoma-clinical-features-and-diagnosis
    Melanoma is the most serious form of skin cancer. As survival rates for people with melanoma depend on the stage of the disease at the time of diagnosis, early diagnosis is crucial to improve patient outcome and save lives. Although most melanomas are detected by patients themselves, clinician detection is associated with thinner, more curable tumors. Most patients with thin, invasive melanoma (Breslow thickness ≤1 mm) can expect prolonged disease-free survival and likely cure following treatment. […] This topic will discuss the clinical features and diagnosis of cutaneous melanoma. The principles and rationale of screening and early detection of melanoma are discussed separately, as are the histopathologic features, initial management, and staging of melanoma. The clinical features, diagnosis, and management of mucosal melanoma, ocular melanoma, and melanoma in children are also discussed separately.
  • #1 I’ve been diagnosed with melanoma. Now what?
    https://www.aad.org/public/diseases/skin-cancer/types/common/melanoma/after-diagnosed
    Learning that you have melanoma, the most serious type of skin cancer, can make it difficult to hear anything else your doctor says. After leaving the office, you may wonder what happens next. […] The following picture shows the steps often included in this process. […] You may have had a complete skin exam during your last dermatology appointment. Dermatologists often perform this exam when a patient has a suspicious spot on their skin that could be skin cancer. […] If you did not have a complete skin exam before being diagnosed with melanoma, you’ll have one at your next appointment. […] The stage of the melanoma tells you: How deeply the cancer cells have reached into the skin. Whether the cancer has spread beyond the skin. […] Your dermatologist or oncologist (doctor who specializes in cancer) uses the stage to determine how best to treat the cancer.
  • #1 Melanoma Treatment – NCI
    https://www.cancer.gov/types/skin/patient/melanoma-treatment-pdq
    Melanoma can recur (come back) after it has been treated. […] Treatment of stage 0 is usually surgery to remove the area of abnormal cells and a small amount of normal tissue around it. […] Treatment of stage I melanoma is usually surgery to remove the tumor and some of the normal tissue around it, with or without lymph node mapping and sentinel lymph node biopsy. […] Treatment of stage II melanoma may include surgery to remove the tumor and some of the normal tissue around it, with lymph node mapping and sentinel lymph node biopsy. […] Treatment of stage III melanoma that can be removed by surgery may include immunotherapy with pembrolizumab before surgery. […] Treatment of stage III melanoma that cannot be removed by surgery, stage IV melanoma, and recurrent melanoma may include immunotherapy with pembrolizumab, nivolumab, ipilimumab, interleukin-2 (IL-2), nivolumab and relatimab, or atezolizumab, given alone or in combination.
  • #1 I’ve been diagnosed with melanoma. Now what?
    https://www.aad.org/public/diseases/skin-cancer/types/common/melanoma/after-diagnosed
    Observation (or more treatment) may be recommended for a patient in any stage. […] After you finish treatment, your dermatologist (or oncologist) will still want to see you regularly. Melanoma can return or spread after treatment. […] It’s extremely important that you examine your skin and lymph nodes as often as your dermatologist or oncologist recommends. […] Dermatologists recommend that anyone who has had melanoma perform skin self-exams for life.
  • #1 Melanoma Diagnosis | Memorial Sloan Kettering Cancer Center
    https://www.mskcc.org/cancer-care/types/melanoma/diagnosis
    It is not always easy for doctors to tell the difference between an unusual but noncancerous mole and a melanoma. A diagnosis can sometimes be challenging to make. Memorial Sloan Kettering is one of the few hospitals in the United States with access to advanced diagnostic techniques that can help accurately evaluate a tumor. […] At Memorial Sloan Kettering, sophisticated pathology and imaging tests provide our care teams with a great deal of information. The pathologists and other experts who perform these tests focus on skin cancer care and melanoma in particular. This training gives our team the expertise to ensure that you get the right diagnosis and to personalize your care as much as possible.
  • #2 Malignant Melanoma – Malignant melanoma treatment | Quest Diagnostics | Quest Diagnostics
    https://www.questdiagnostics.com/healthcare-professionals/diagnostic-insights/articles/2022/malignant-melanoma-laboratory-testing
    Malignant melanoma (melanoma) is a cancer of melanocytes that most often occurs on the skin primarily due to excess sun exposure. The American Cancer Society (ACS) estimates that in 2022 about 100,000 new cases of melanoma will be diagnosed and about 7,500 people will die from the disease. When melanoma is diagnosed early (localized disease; the cancer has not spread beyond the region of skin where it started), the 5-year relative survival rate approaches 100%. However, melanoma is an aggressive malignancy, with early regional and distant metastasis, and the 5-year survival rate in patients with distant metastases is only about 16%. […] Diagnosis of melanoma combines visual screening, biopsy, and histological examination as discussed below. […] While physical characteristics of a pigmented lesion can raise the suspicion of melanoma, definitive diagnosis requires a biopsy of the lesion and examination of the tissue specimen by an experienced dermatopathologist. American Academy of Dermatology (AAD) guidelines indicate that a biopsy can be incisional (removing part of the lesion) or excisional (removing the entire lesion).
  • #2 Melanoma Diagnosis: Biopsy, Genetic Testing & Other Tests
    https://www.cancercenter.com/cancer-types/melanoma/diagnosis-and-detection
    Estimated number of 2022 new melanomas diagnosed in men and women In 2025, approximately 104,960 people will be diagnosed with melanoma, and about 8,430 melanoma patients will die of the disease. […] The Melanoma Research Foundation and the American Cancer Society (ASC) recommend monthly self-examinations and annual doctor visits to screen for potential skin cancer, but only a doctor can determine whether a suspicious spot or mole is melanoma. […] Some tests designed for diagnosing melanoma include: […] Your doctor may remove the suspicious growth, or a piece of it, for examination by a laboratory, where the pathologist will inspect the sample for cancerous cells. […] Various biopsy methods are used in diagnosing skin cancers. […] Melanoma biopsies can be excisional or incisional. An excisional biopsy takes off the entire lesion along with a small margin of normal skin around it, while an incisional biopsy removes only part of a suspicious lesion.
  • #2 Melanoma – Diagnosis and treatment – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/melanoma/diagnosis-treatment/drc-20374888
    Excisional biopsy of the skin […] During an excisional biopsy, a scalpel is used to cut out a lump or an area of irregular skin and some surrounding healthy skin. As a rule, stitches are needed to close the wound. […] During a punch biopsy, a round-tipped cutting tool is used to remove deeper layers of skin for testing. Depending on the size, stitches may be needed to close the wound. […] Tests and procedures used to diagnose melanoma include: […] Your healthcare professional will ask questions about your health history. That person also will examine your skin to look for signs that could mean melanoma. […] A biopsy is a procedure to remove a sample of tissue for testing in a lab. What type of biopsy procedure is used depends on your situation. Most often healthcare professionals recommend removing the entire growth when possible.
  • #2 How We Diagnose Melanoma | Dana-Farber Cancer Institute
    https://www.dana-farber.org/cancer-care/types/melanoma/diagnosis
    At the Center for Melanoma Oncology at Dana-Farber Brigham Cancer Center, our specialists care for you and manage your diagnosis as a team. […] We are one of the few centers in the world with a team of pathologists and clinicians who focus exclusively on diagnosing and evaluating melanoma. […] If you are diagnosed with melanoma, our team uses a series of tests to better understand the extent of the disease and to determine the right treatment for you. […] Your doctor may conduct the following tests and procedures: A skin exam checks for moles, birthmarks, or other pigmented areas that look abnormal in color, size, shape, or texture. […] During a biopsy, your doctor may remove all or part of the abnormal skin and a small amount of normal tissue around it. A pathologist looks at the tissue under a microscope to check for cancer cells.
  • #2 Cancer Society NZ — Diagnosing melanoma skin cancer
    https://www.cancer.org.nz/cancer/types-of-cancer/melanoma-of-the-skin/diagnosing-melanoma-skin-cancer/
    Most of us have spots on our skin. It’s important to notice any changes in the size, shape, and/or colour of your spots or moles. […] If you see a new spot or a change in an existing spot or mole, it needs to be checked by your doctor or a skin specialist. Your doctor checks the spots that have changed and do a general check of your skin. They will use a handheld magnifying tool called a dermatoscope to look at the spot or mole and judge it by the “ABCDE” criteria: Asymmetry The spot has an irregular shape. Border The spot has uneven or scalloped edges. Colour The spot has different shades and colour patches. Diameter The spot is usually over 6mm wide across. Evolving The spot is changing and growing. […] Your doctor will also ask if you or anyone in your family/whānau have had a melanoma or other skin cancer before. They may also feel the lymph nodes (glands) in the area nearest your spot or mole to check if they are swollen.
  • #2 I’ve been diagnosed with melanoma. Now what?
    https://www.aad.org/public/diseases/skin-cancer/types/common/melanoma/after-diagnosed
    Learning that you have melanoma, the most serious type of skin cancer, can make it difficult to hear anything else your doctor says. After leaving the office, you may wonder what happens next. […] The following picture shows the steps often included in this process. […] You may have had a complete skin exam during your last dermatology appointment. Dermatologists often perform this exam when a patient has a suspicious spot on their skin that could be skin cancer. […] If you did not have a complete skin exam before being diagnosed with melanoma, you’ll have one at your next appointment. […] The stage of the melanoma tells you: How deeply the cancer cells have reached into the skin. Whether the cancer has spread beyond the skin. […] Your dermatologist or oncologist (doctor who specializes in cancer) uses the stage to determine how best to treat the cancer.
  • #2 Tests For Melanoma Skin Cancer | Melanoma Diagnosis | American Cancer Society
    https://www.cancer.org/cancer/types/melanoma-skin-cancer/detection-diagnosis-staging/how-diagnosed.html
    The doctor may also feel the lymph nodes (small bean-sized collections of immune cells) under the skin in the neck, underarm, or groin near the abnormal area. […] When melanoma spreads, it often goes to nearby lymph nodes first, making them larger. […] If the doctor thinks a spot might be a melanoma, the suspicious area will be removed and sent to a lab to be looked at under a microscope. This is called a skin biopsy. […] There are many ways to do a skin biopsy. […] No matter which type of biopsy is done, it should remove as much of the suspected area as possible so that an accurate diagnosis can be made. […] Biopsies of areas other than the skin may be needed in some cases. […] For example, if melanoma has already been diagnosed on the skin, nearby lymph nodes may be biopsied to see if the cancer has spread to them.
  • #2 Melanoma Detection & Diagnosis | Mount Sinai – New York
    https://www.mountsinai.org/locations/waldman-melanoma-center/detection-diagnosis
    The Kimberly and Eric J. Waldman Melanoma and Skin Cancer Center offers the most up-to-date diagnostic methods available. […] Regular dermatologist appointments are important, especially if you’ve spent a lot of time in the sun. Your dermatologist will gather information in a variety of ways to make a diagnosis. […] If your doctor suspects you have a skin cancer, they may perform a biopsy in order to make a diagnosis and—if skin cancer is present—begin the treatment process. […] The Center also offers the latest advances in detection and diagnosis—many of which are less invasive than biopsy. […] The Kimberly and Eric J. Waldman Melanoma and Skin Cancer Center is one of the few facilities in the world to offer digital 3D total body photography to detect skin cancer. […] Reflectance confocal microscopy is an innovative imaging tool that allows your doctor to see deeper into the skin without cutting.
  • #2 Confirming Your Diagnosis of Melanoma Skin Cancer – MRA
    https://www.curemelanoma.org/patient-eng/diagnosing-melanoma/confirming-the-diagnosis
    After identifying a suspect lesion, your doctor may suggest either removing it outright or further testing. Further testing is sometimes suggested because even after careful examination, it is not always clear if a suspicious mole or lesion is cancerous. […] The gold standard for determining if a suspicious mole is cancerous is a biopsy with thorough pathological examination. However, biopsies are not always needed or ideal and may not be appropriate due to the associated scarring, costs, or the presence of preexisting conditions that make healing more difficult. […] This is especially true for sensitive areas, such as the face or ears. […] Despite being the gold standard for diagnosing melanoma, it is not a perfect tool. […] Due to these concerns, many doctors are turning to non-invasive techniques that can give them more information instead of or before a traditional biopsy.
  • #2 Melanoma – Diagnosis and treatment – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/melanoma/diagnosis-treatment/drc-20374888
    One common technique is called the punch biopsy. A punch biopsy is done with a circular blade that’s pressed into the skin around the suspicious mole. […] Another technique is called an excisional biopsy. An excisional biopsy uses a scalpel to cut away the entire mole and some of the healthy tissue around it. […] If you receive a diagnosis of melanoma, the next step is to determine the extent of the cancer, called the stage. […] To assign a stage to your melanoma, your healthcare team will: […] Determine the thickness. In general, the thicker the melanoma, the more serious the disease. The thickness of a melanoma is determined by looking at the melanoma under a microscope and measuring it with a special tool. The thickness of a melanoma helps your care team decide on a treatment plan.
  • #2 Current state of melanoma diagnosis and treatment
    https://pmc.ncbi.nlm.nih.gov/articles/PMC6804807/
    Furthermore, in 1966 Clark proposed a system for evaluating melanoma based the depth of invasion of melanoma cells into the dermis and subcutaneous fat. […] The Clark levels still remain a standardized way to convey information related to risk of disease aggressiveness and are reported in melanoma reports by some pathologists, however in 1970 Alexander Breslow independently devised a more accurate method for classifying melanoma based on a measured depth of invasion that captured the thickness of the tumor. […] The most recent revision of the AJCC staging manual (8th edition) was released in 2016 and implemented in 2018. […] Staging is vitally important as it gives clinicians the tools to assess patient prognosis and put together a treatment regimen that will give the patient the best possible chance for recovery or prolonged survival.
  • #2 Confirming Your Diagnosis of Melanoma Skin Cancer – MRA
    https://www.curemelanoma.org/patient-eng/diagnosing-melanoma/confirming-the-diagnosis
    One example of a non-invasive test that can help doctors and patients decide whether to biopsy a suspicious skin lesion is the DermTech Melanoma Test (DMT). […] The DermTech Melanoma Test has a negative predictive value exceeding 99%, which means that over 99% of lesions that contain no melanoma-associated markers using the test are truly negative for melanoma. […] Since a biopsy is the gold standard for making a melanoma diagnosis, your doctor may suggest a biopsy regardless of your non-invasive testing result. […] A skin biopsy is a minor medical procedure performed on a suspicious spot to retrieve a sample of cells, which will then be carefully examined under a microscope by an expert called a pathologist. […] The pathologist will test cells from your biopsy sample and provide you and your doctor with a comprehensive report based on their findings.
  • #2 Confirming Your Diagnosis of Melanoma Skin Cancer – MRA
    https://www.curemelanoma.org/patient-eng/diagnosing-melanoma/confirming-the-diagnosis
    In approximately 10-15% of biopsy samples, visual examination of the cells under a microscope alone is insufficient for a pathologist to make a definitive diagnosis. […] In these cases, your pathologist has several other tools to help arrive at a definitive diagnosis. […] In a Gene Expression Panel (GEP), a group of genes related to cancer are analyzed collectively to aid a pathologist in determining if cells are cancerous or benign. […] The myPath Melanoma test result is provided as a single numerical score that classifies skin lesions as likely benign, likely malignant, or indeterminate.
  • #2 Understanding Your Pathology Report: Melanoma | OncoLink
    https://www.oncolink.org/cancers/skin/melanoma/treatments/understanding-your-pathology-report-melanoma
    A pathologist is a doctor who diagnoses diseases by looking at tissue from the body. Samples of your melanoma tissue, removed during surgery or biopsy, will be sent to a pathologist to look at under a microscope. The pathology report goes over what the pathologist finds. This report has important information about your tumor. This is used to help guide treatment decisions for you. You should ask for a copy of this report to keep. […] The report will give the type of melanoma and some information about it that is needed for prognosis (prediction of the course of the disease) and treatment. […] Breslow’s depth of invasion measures the thickness of a melanoma, at its thickest point, in millimeters. This is important for prognosis. For example, a thicker melanoma has a poorer prognosis. Breslow thickness is more important than the tumor’s Clark’s Level in figuring out the prognosis.
  • #2 Understanding Your Melanoma Diagnosis & Pathology Report – Melanoma Research Alliance
    https://www.curemelanoma.org/patient-eng/ten-tips-for-people-just-diagnosed-with-melanoma/get-educated
    In the case of a melanoma, the pathology report may tell you whether the tissue removed is a primary melanoma, which means the melanoma started in the location it was removed from. Alternatively, the tissue may be a metastatic melanoma deposit, which means that the melanoma started somewhere else on the body and then spread to the current location. […] The stage of melanoma will be determined twice: the clinical stage is determined after a biopsy, and the pathologic stage is determined after surgery to remove the entire lesion. […] Breslow thickness and Clark level. These are measurements of how deep the melanoma has invaded into the skin. […] Maximum tumor thickness in millimeters (mm). […] Ulceration: Breaking of the top layer of skin. Options are present or absent. […] Mitotic index or mitoses: Given in number per square millimeter (mm2), this tells how fast the cancer cells are dividing.
  • #2 Melanoma Diagnosis | Memorial Sloan Kettering Cancer Center
    https://www.mskcc.org/cancer-care/types/melanoma/diagnosis
    Genomic testing is also called tumor sequencing or molecular profiling. It involves looking at the cells obtained from the melanoma to see if there are any genetic mutations (changes in the genes) that could be linked to the type of cancer. […] For people with advanced disease, our experts use a testing approach called MSK-IMPACT. This test, developed by MSK experts, screens for mutations in more than 450 genes at once. […] Based on which mutations we find, we may be able to recommend a targeted therapy that has been approved for the specific changes in the tumor. Some MSK patients may be able to join a melanoma clinical trial testing a new drug therapy. […] Genetic information about the tumor can also help us predict the chances that the cancer will return after treatment and avoid treatments that wont work.
  • #2 Diagnosis & Tests for Melanoma
    https://www.texasoncology.com/types-of-cancer/melanoma/diagnosis-tests-for-melanoma
    During a SLN biopsy, the physician removes the SLN through a small incision and then a pathologist examines the SLN under the microscope to detect whether or not there is any evidence of melanoma cells. […] There is evidence that surgical removal of involved lymph nodes may improve survival. […] Melanoma can spread by local extension (through the lymph system, as described above) and/or by the blood to distant sites. […] In 3-5% of patients, melanoma is present in lymph nodes or other organs without an identifiable primary site and these patients are said to have melanoma of unknown origin. […] The purpose of looking for biomarkers and genomic alterations in the cancers DNA is to identify targets that can be treated with precision cancer medicines. […] Testing for biomarkers or genomic alterations is performed to identify genetic mutations or the proteins they produce because the results can help select treatment including newer precision cancer medicines designed to attack specific colon cancer cells with specific genetic mutations.
  • #2 Cutaneous Diagnosis – Melanoma Research Foundation
    https://melanoma.org/cutaneous-melanoma/cutaneous-diagnosis/
    The Breslow thickness is a better melanoma stage diagnostic indicator than the Clarks level; it is a continuous variable and more accurate in its determinations. […] Tumor thickness remains the most powerful prognostic indicator that can be determined from evaluation of the primary melanoma itself. […] The extent of lymph node involvement, as well as several other factors, will help determine the stage of diagnosis. […] Staging melanoma is the process used to describe the extent of the disease. The doctor will take into account the tumor thickness and depth and whether the melanoma cells have spread to the lymph nodes or other parts of the body. […] The American Joint Committee on Cancer (AJCC) staging system is used to stage melanoma. The AJCC uses the TNM system to determine the melanoma stage.
  • #2 Melanoma Diagnosis | MD Anderson Cancer Center
    https://www.mdanderson.org/cancer-types/melanoma/melanoma-diagnosis.html
    After melanoma has been diagnosed, tests may be recommended to find out if cancer cells have spread within the skin or to other parts of the body. […] If you are diagnosed with melanoma skin cancer, your doctor will determine the stage (or extent) of the disease. Staging is a way of determining how much disease is in the body and where it has spread. This information is important because it helps your doctor determine the best type of treatment for you and the outlook for your recovery (prognosis). […] Stages 1 and 2 are based mainly on the thickness of the primary melanoma and other microscopic features. Stages 3 and 4 are based on how far the melanoma has spread from the skin; stage 3 melanoma signifies regional spread and stage 4 melanoma is based on distant spread.
  • #2 Melanoma Treatment – NCI
    https://www.cancer.gov/types/skin/patient/melanoma-treatment-pdq
    Melanoma can occur anywhere on the skin. […] Tests that examine the skin are used to diagnose melanoma. […] After melanoma has been diagnosed, tests may be done to find out if cancer cells have spread within the skin or to other parts of the body. […] Signs of melanoma include a change in the way a mole or pigmented area looks. […] The process used to find out if cancer cells have spread beyond the skin is called staging. To plan treatment, it is important to know the stage of the disease. […] The stage of melanoma depends on the thickness of the tumor, whether cancer has spread to lymph nodes or other parts of the body, and other factors. […] The following stages are used for melanoma: Stage 0 (melanoma in situ), Stage I (also called stage 1) melanoma, Stage II (also called stage 2) melanoma, Stage III (also called stage 3) melanoma, Stage IV (also called stage 4) melanoma.
  • #2 Melanoma Stages 0, 1, 2, 3 and 4 Metastatic | Memorial Sloan Kettering Cancer Center
    https://www.mskcc.org/cancer-care/types/melanoma/diagnosis/melanoma-stages
    Breslow depth is the tumors thickness. It measures how deep below the surface of the skin the melanoma cells have reached. The thinner the melanoma, the better the chance for a cure. We measure tumors in millimeters. […] Staging also is based on whether the skin is broken. […] Ulceration means there is broken skin covering the melanoma. This break can be so small it can only be seen under a microscope. Ulceration is important for staging. A melanoma with ulceration is higher risk than the same thickness melanoma without ulceration. […] What is Stage 0 Melanoma? The scale starts at stage 0 melanoma. This is melanoma in the thin outer layer of the skin. It is not invasive and will not spread to other parts of the body. This often is called melanoma in situ. […] What is Stage 1 Melanoma? Melanoma at stage 1 is invasive. It has grown below the thin outer layer of the skin to the next layer of skin. It has not spread to lymph nodes.
  • #2 How We Diagnose Melanoma | Dana-Farber Cancer Institute
    https://www.dana-farber.org/cancer-care/types/melanoma/diagnosis
    The stage is based on: The depth of the original melanoma and other pathologic features of the original melanoma. […] In stage 0, melanoma is only in the epidermis (outer layer) of the skin. It is usually curable when removed with adequate margins. […] The tumor may be any thickness, with or without ulceration. One or more of the following applies: Cancer has spread to one or more lymph nodes. […] It is important to be seen quickly if you’ve been diagnosed with melanoma so you can start treatment. […] Some reasons to consider a second opinion include: To confirm your diagnosis and stage of melanoma.
  • #2 DecisionDx-Melanoma: The Leader in Genetic Testing for Melanoma
    https://castlebiosciences.com/tests/prognostic/decisiondx-melanoma/overview
    AJCC staging alone suggests a 98% survival rate for Stage I melanoma. Combined with DecisionDx class 1A results, the survival rate is 99.7%. Combine with DecisionDx class 2B results, the survival rate is 92.8%. […] The test was an independent predictor of patient outcomes. Testing was associated with a 29% lower melanoma-specific mortality and a 17% lower overall mortality relative to patients who did not receive DecisionDx-Melanoma testing. […] The study found that routine surveillance imaging in SLN negative, high-risk patients detected melanoma recurrence ~10 months earlier than those without routine imaging and that patients tested had better overall survival than those not tested. […] These results are consistent with previous studies that the 31-GEP can identify patients at low risk of SLN positivity and recurrence.
  • #2 Diagnosis of melanoma skin cancer | Canadian Cancer Society
    https://cancer.ca/en/cancer-information/cancer-types/melanoma-skin/diagnosis
    During a skin biopsy, the doctor removes tissues or cells from the skin so they can be tested in a lab. A report from the pathologist will confirm whether or not cancer cells are found in the sample. The type of biopsy used often depends on what the growth looks like and its size. […] An excisional biopsy is the best type of biopsy to make a proper diagnosis of melanoma. […] A lymph node biopsy removes a lymph node or some lymph node tissue so it can be tested for cancer in a lab. It is done if the doctor thinks the cancer has spread to lymph nodes. […] Cells and tissues can be studied in a lab to look for signs of cancer. They can show certain changes in the body. Melanoma cell and tissue samples are usually collected during a biopsy. […] A CT scan of the chest, abdomen and pelvis is used to check if melanoma has spread to other parts of the body.
  • #2 Tests After Diagnosis – AIM at Melanoma Foundation
    https://www.aimatmelanoma.org/melanoma-101/how-melanoma-is-diagnosed/additional-evaluation/
    What Happens After Being Diagnosed With Melanoma? The following information will help you understand what further tests might be ordered after an initial melanoma diagnosis and why they would be used. Nearly all melanoma diagnoses that emerge from a biopsied skin sample will be staged as Stage 0, Stage I, or Stage II because that sample doesn’t reveal whether the melanoma has metastasized (spread) into lymph nodes (Stage III) or organs elsewhere in the body (Stage IV). A rare exception—when a biopsied skin sample would not be staged as Stage 0, I, or II—would be a skin biopsy that turns out to be a metastasized tumor that is a result of spreading from another primary tumor elsewhere on the skin. If you have been given a melanoma diagnosis of Stage 0, Stage I, or Stage II, you should see a dermatologist who has experience with melanoma to discuss your next steps. Your dermatologist will study the pathology report, gather your complete medical history, and perform a complete physical examination if these things have not already been done. S/he will refer you to other physicians as necessary. Your dermatologist will refer you to a general surgeon or a surgical oncologist for a wide local excision. A wide local excision is the standard surgical procedure for early-stage primary melanoma, in which the tumor, including the biopsy site and a surgical margin (the area of normal tissue around the biopsy site), are removed. The goal is complete removal of the Stage 0, Stage I, or Stage II tumor. Your doctor will compare the details in your pathology report, your history, and your examination results with accepted guidelines that assess the risk of spread (metastases). If the risk is low that your melanoma has spread, you will likely not receive any further tests to look for spread. If there is a certain amount of risk of spread, further testing might be ordered to look for potential spread. Factors such as ulceration, the Breslow depth of the tumor, and age are all considered in risk assessment. Further testing may include the following: Sentinel Lymph Node Biopsy (SLNB) Lymph nodes, part of the body’s lymphatic system, are small bean-shaped organs that help fight infection. There are large groups of lymph nodes on both sides of the neck, in the armpits, and in the groin. If there is high enough risk that the melanoma has grown into the inner layers of the skin and into the lymphatic system, your doctor may order a sentinel lymph node biopsy. The presence or absence of melanoma cells in the lymph nodes is one of the most important prognostic factors we have since it indicates whether there is high risk of recurrence as well as the type of treatment you may need. The SLNB is a surgical procedure during which a small amount of radioactive substance is injected into the area where the melanoma was removed. The lymph nodes that absorb the injected fluid first are the sentinel lymph nodes. There are usually between one and five sentinel nodes. If the cancer has spread, the sentinel nodes are the most likely node to have cancer within them. The surgeon will remove these nodes and check them for cancer cells. The removal of the sentinel lymph nodes is usually done under a general anesthetic at the same time as the wide local excision. Fine Needle Aspiration Biopsy During the physical exam, your doctor will have felt the lymph nodes nearest the melanoma to see if they are enlarged, irregular, or firm, because such nodes may indicate the cancer has spread to the lymph nodes. If they are enlarged, irregular, or firm, your doctor may recommend a fine needle aspiration biopsy. A fine needle aspiration biopsy is performed with local anesthetic. A slender needle is placed through the skin and into the suspicious lymph node. A small tissue sample is removed when the needle is withdrawn. An ultrasound or CT scan is often used to guide the needle to the correct node. The sample is then examined under a microscope to see if it contains cancer. X-Ray An x-ray may be used to look for spread. Ultrasound An ultrasound uses sound waves to create a picture of the internal organs, including collections of lymph nodes, called lymph node basins, and soft tissue. The picture can reveal potential spread. Computed Tomography (CT or CAT) Scan A CT scan creates a 3-dimensional picture of the inside of the body using x-rays taken from different angles. A computer combines these images into a detailed, cross-sectional view that shows any abnormalities or tumors. If melanoma has spread, a CT scan can be used to measure the tumor’s size. Sometimes, a special dye called a contrast medium is given before the scan to provide better detail on the image. This dye can be injected into a patient’s vein and/or given as a liquid to swallow. Magnetic Resonance Imaging (MRI) An MRI uses magnetic fields, not x-rays, to produce detailed images of the body. MRI can be used to measure the tumor’s size. A special dye called a contrast medium is given before the scan to create a clearer picture. This dye is injected into a patient’s vein. Positron Emission Tomography (PET) or PET-CT Scan A PET scan is usually combined with a CT scan (see above), called a PET-CT scan. However, you may hear your doctor refer to this procedure just as a PET scan. A PET scan is a way to create pictures of organs and tissues inside the body. A small amount of a radioactive sugar substance is injected into the patient’s body. This sugar substance is taken up by cells that use the most energy. Because cancer tends to use energy actively, it absorbs more of the radioactive substance. A scanner then detects this substance to produce images of the inside of the body and identify areas in which melanoma may have spread. If your doctor performs one or more of these tests and spread is revealed, you will be re-staged to account for the new information. If you have a sentinel lymph node biopsy or fine needle aspiration biopsy, you will also receive a new pathology report for that biopsy. Just like with the skin biopsy pathology report, details of your melanoma will be given, as well as the TNM staging information. If your doctor performs one or more of these tests and no spread is revealed, your stage remains the one that was given to you after your skin biopsy. You should continue seeing a dermatologist to check for new melanomas and any indication of spread or recurrence. If you are Stage IIB or IIC, you should consider seeing a medical oncologist who specializes in melanoma. In years past, only patients Stage III and higher were referred to medical oncologists and offered treatment. But now there are clinical trials open or opening that are studying whether giving certain treatments at Stage IIB and IIC will help prevent the recurrence of melanoma versus giving no drug treatment, which is the standard of care now.
  • #2 Current state of melanoma diagnosis and treatment
    https://pmc.ncbi.nlm.nih.gov/articles/PMC6804807/
    Ultimately, there is no perfect diagnostic or prognostic biomarker for melanoma. […] The treatment of metastatic melanoma has greatly improved in recent years with the introduction of treatments such as BRAF, CTLA4 and PD1 inhibitors. […] Research into how and why these treatments succeed or fail is ongoing.
  • #2 LCD – MolDX: Molecular Assays for the Diagnosis of Cutaneous Melanoma (L39389)
    https://www.cms.gov/medicare-coverage-database/view/lcd.aspx?lcdid=39389&ver=3
    Consequently, adjuncts to histopathology have been sought in efforts to improve diagnostic accuracy in equivocal cases. […] Gene expression profiles (GEP) can serve as beneficial adjuncts to histopathology in the evaluation of equivocal melanocytic lesions. […] The myPath Melanoma assay is a 23-gene expression profile (23-GEP) developed to provide an objective, reproducible, and accurate adjunctive method for differentiating malignant melanoma from benign nevi. […] The test is intended for use by dermatopathologists confronting primary cutaneous melanocytic neoplasms for which the diagnosis of malignant melanoma versus benign nevus is equivocal/uncertain. […] Histopathology can accurately classify many melanocytic neoplasms and currently serves as the gold standard for the diagnosis of melanoma.
  • #2 Melanoma Diagnosis | MD Anderson Cancer Center
    https://www.mdanderson.org/cancer-types/melanoma/melanoma-diagnosis.html
    Early and accurate melanoma skin cancer diagnosis is important. This helps find out if the melanoma has spread and helps your doctor choose the most effective treatment. […] MD Anderson has the most modern and accurate technology to diagnose melanoma and find out if it has spread. This helps increase the likelihood that your treatment will be successful. Our staff includes pathologists and diagnostic radiologists who are highly skilled in diagnosing melanoma. […] If your doctor suspects a spot may be melanoma, a biopsy will be done. […] Melanoma skin cancer cannot be diagnosed just by looking at it. […] A biopsy should be performed first to determine if the area is malignant. […] Because melanoma can be hard to diagnose, you should consider having your biopsy checked by a second pathologist.
  • #2 Melanoma | Better Health Channel
    https://www.betterhealth.vic.gov.au/health/conditionsandtreatments/melanoma
    Melanoma is the most dangerous type of skin cancer. […] Melanoma is diagnosed by: physical examination including medical history; excision biopsy under local anaesthetic, the suspected melanoma and some of the surrounding skin is removed. The sample will be examined in a laboratory for signs of cancer. […] If a melanoma is diagnosed, further tests may be needed if surgery is planned or to see if the cancer has spread to other areas of the body. These tests may include: blood tests; chest x-ray; ultrasound scan; magnetic resonance imaging (MRI) scan; computed tomography (CT) scan; bone scan; lymph node biopsy. […] Most people with melanoma need to have surgery. In some cases, melanomas may be treated by immunotherapy and targeted therapy, and (less frequently) radiotherapy. […] Melanomas are usually removed by surgery (except when the melanoma is too advanced). The surgeon also removes some normal-looking skin around the melanoma. This is called a 'margin of safety’ and the margin varies from 5 mm to 2 cm.
  • #2 Skin cancer types: Melanoma Diagnosis and treatment
    https://www.aad.org/public/diseases/skin-cancer/types/common/melanoma/diagnose-treat
    If you have melanoma, many factors affect your life expectancy. Your age, other medical conditions, and stage of the melanoma are just a few factors. […] Survival rate is the percentage of people who will be alive within a certain time period, such as 5 years, after being diagnosed with a certain stage of melanoma. Each stage of melanoma has its own survival rate. […] Newer treatments, such as immunotherapy and targeted therapy, are helping people live longer.
  • #2 I’ve been diagnosed with melanoma. Now what?
    https://www.aad.org/public/diseases/skin-cancer/types/common/melanoma/after-diagnosed
    When your dermatologist found a spot on your skin that looked like a skin cancer, your dermatologist performed a skin biopsy. […] The skin that your dermatologist removed was then sent to a lab, where another doctor looked at it under a microscope. This doctor saw melanoma cells. […] Some but not all patients need testing. Testing can help find out whether the melanoma has spread beyond the skin. […] The goal of treatment is to remove all of the cancer. For this reason, surgery is often part of the treatment plan. […] When found early, a type of surgery called excision surgery may be the only treatment you need. […] If the cancer is deep or has spread, surgery becomes more complex. Surgery would be performed in an operating room. […] If your dermatologist recommends a sentinel lymph node biopsy, it will also be performed in an operating room at a hospital.
  • #2 Skin cancer types: Melanoma Diagnosis and treatment
    https://www.aad.org/public/diseases/skin-cancer/types/common/melanoma/diagnose-treat
    When the stage cannot be determined from the biopsy, your dermatologist will recommend more testing. […] The type of treatment you receive depends on the following: How deeply the melanoma has grown into your skin, Whether the cancer has spread to another part of your body, Your overall health. […] Your dermatologist, oncologist (cancer doctor), or oncology (cancer) team will consider the above when creating your treatment plan, which may include one or more of the following treatments. […] When melanoma grows deeper into the skin or spreads, treatment becomes more complex. […] The other types of treatment for melanoma are: Lymphadenectomy: Surgery to remove lymph nodes, Immunotherapy: Medication is used to help the patients immune system find and destroy cancer cells, Targeted therapy: These drugs target cancer cells and can temporarily shrink the cancer, Chemotherapy: These medications kill fast-growing cells, which include cancer cells and some normal cells, such as hair cells, Radiation therapy: This is used to either kill the cancer cells or stop new cancer cells from forming.
  • #2 Diagnosing Melanoma Correctly 
    https://www.thesunbus.org/diagnosis
    The survival rate is the percentage of people who live at least a certain amount of time after being diagnosed with cancer. […] The more that newly diagnosed melanoma patients know about how to manage their care and its side effects, the better they will feel in the long run. […] After treatment, your doctors will still want to monitor your skin closely. […] This is why it is important to keep all follow-up appointments.
  • #2 Diagnosis – Melanoma – Cancer Institute | Northwell Health
    https://cancer.northwell.edu/cancer-care/melanoma/diagnosis
    At Northwell, we use the most advanced diagnostic tools and processes for early and accurate melanoma diagnosis. […] An accurate and early diagnosis is especially important in melanoma because it could literally save your life. It starts with a skin exam to check for moles, birthmarks or other pigmented areas of the skin that look abnormal in color, size, shape or texture. Your doctor may take a biopsy, a small sample of tissue from the affected area that is examined under a microscope to check for cancer cells. If cancer is suspected, your doctor will order blood and imaging tests to determine if or how far the cancer has spread in your body. This process is called staging, and its vital for effective treatment. […] Our specialists use the most advanced diagnostic tools and processes for a timely and accurate diagnosis for the best possible outcome.
  • #2 Diagnosis | Stanford Health Care
    https://stanfordhealthcare.org/medical-conditions/cancer/melanoma/patient-care-resources/diagnosis.html
    To establish or confirm a diagnosis, your doctor reviews your health records and completes a physical exam, particularly of your skin and lymph nodes. Your doctor may recommend certain tests, including: […] During a biopsy, your doctor (usually a dermatologist) removes as much of the visible skin tumor as possible. A dermatopathologist examines the tissue under a microscope to determine whether the cells are normal or cancerous. […] Your doctor may recommend genetic testing if you have a family history of melanoma or a confirmed gene mutation related to melanoma. […] If your doctor suspects the cancer is advanced (has spread), specialized imaging tests are performed to provide detailed pictures of organs below your skin’s surface. […] Also called blood tests or draws, a small blood sample is removed to analyze for markers of disease spread. Your doctor orders a blood draw if you have a more advanced stage of melanoma or are taking drugs for melanoma that has spread to lymph nodes or other body sites. Blood tests provide a variety of information that helps doctors plan your treatment.
  • #3 Melanoma Screening and Diagnosis – UChicago Medicine
    https://www.uchicagomedicine.org/cancer/types-treatments/melanoma/screening-diagnosis
    Dermatologists use specialized tools called dermatoscopes that use polarized light and magnification to get a better view of your skin. […] Early detection is important because melanoma can usually be cured in its early stages. […] Having a skin cancer screening at least once a year can help you catch early signs of melanoma and other skin cancers. […] When needed, they use instruments called dermatoscopes that can accurately detect melanoma and other skin cancers. […] At the University of Chicago Medicine, our skilled dermatologists are experts in skin cancer screening in people of all races and ethnicities. […] Mole mapping uses more advanced technology than skin cancer screenings and can offer peace of mind if you have many moles or have risky moles that are an unusual size, shape or color.
  • #3 Melanoma Diagnosis | MD Anderson Cancer Center
    https://www.mdanderson.org/cancer-types/melanoma/melanoma-diagnosis.html
    Early and accurate melanoma skin cancer diagnosis is important. This helps find out if the melanoma has spread and helps your doctor choose the most effective treatment. […] MD Anderson has the most modern and accurate technology to diagnose melanoma and find out if it has spread. This helps increase the likelihood that your treatment will be successful. Our staff includes pathologists and diagnostic radiologists who are highly skilled in diagnosing melanoma. […] If your doctor suspects a spot may be melanoma, a biopsy will be done. […] Melanoma skin cancer cannot be diagnosed just by looking at it. […] A biopsy should be performed first to determine if the area is malignant. […] Because melanoma can be hard to diagnose, you should consider having your biopsy checked by a second pathologist.
  • #3 Melanoma and Skin Cancer Symptoms and Diagnosis | UPMC
    https://hillman.upmc.com/cancer-care/melanoma-skin/symptoms-diagnosis
    Melanoma is a type of skin cancer. […] Diagnosing melanoma early is vital in treating these cancers. With a proper diagnosis, you can get treatment and prevent melanoma from spreading to lymph nodes and other organs. […] To learn if you have melanoma or another skin cancer type, doctors at UPMC Hillman Cancer Center may use a: […] Skin exam: Doctors do a head-to-toe check for moles or growths. […] Shave biopsy: Doctors use a small blade (scalpel) to remove a piece of tissue from the top layer of skin. If your doctor suspects melanoma, they may use a different biopsy type that collects a deeper skin sample. […] Excisional biopsy: Doctors use a scalpel to remove the entire mole or growth and a small border of normal skin (margin). This is the most common test doctors use when they suspect melanoma.
  • #3 Tests For Melanoma Skin Cancer | Melanoma Diagnosis | American Cancer Society
    https://www.cancer.org/cancer/types/melanoma-skin-cancer/detection-diagnosis-staging/how-diagnosed.html
    The doctor may also feel the lymph nodes (small bean-sized collections of immune cells) under the skin in the neck, underarm, or groin near the abnormal area. […] When melanoma spreads, it often goes to nearby lymph nodes first, making them larger. […] If the doctor thinks a spot might be a melanoma, the suspicious area will be removed and sent to a lab to be looked at under a microscope. This is called a skin biopsy. […] There are many ways to do a skin biopsy. […] No matter which type of biopsy is done, it should remove as much of the suspected area as possible so that an accurate diagnosis can be made. […] Biopsies of areas other than the skin may be needed in some cases. […] For example, if melanoma has already been diagnosed on the skin, nearby lymph nodes may be biopsied to see if the cancer has spread to them.
  • #3 LCD – MolDX: Molecular Assays for the Diagnosis of Cutaneous Melanoma (L39389)
    https://www.cms.gov/medicare-coverage-database/view/lcd.aspx?lcdid=39389&ver=3
    Consequently, adjuncts to histopathology have been sought in efforts to improve diagnostic accuracy in equivocal cases. […] Gene expression profiles (GEP) can serve as beneficial adjuncts to histopathology in the evaluation of equivocal melanocytic lesions. […] The myPath Melanoma assay is a 23-gene expression profile (23-GEP) developed to provide an objective, reproducible, and accurate adjunctive method for differentiating malignant melanoma from benign nevi. […] The test is intended for use by dermatopathologists confronting primary cutaneous melanocytic neoplasms for which the diagnosis of malignant melanoma versus benign nevus is equivocal/uncertain. […] Histopathology can accurately classify many melanocytic neoplasms and currently serves as the gold standard for the diagnosis of melanoma.
  • #3 Understanding Your Pathology Report: Melanoma | OncoLink
    https://www.oncolink.org/cancers/skin/melanoma/treatments/understanding-your-pathology-report-melanoma
    A pathologist is a doctor who diagnoses diseases by looking at tissue from the body. Samples of your melanoma tissue, removed during surgery or biopsy, will be sent to a pathologist to look at under a microscope. The pathology report goes over what the pathologist finds. This report has important information about your tumor. This is used to help guide treatment decisions for you. You should ask for a copy of this report to keep. […] The report will give the type of melanoma and some information about it that is needed for prognosis (prediction of the course of the disease) and treatment. […] Breslow’s depth of invasion measures the thickness of a melanoma, at its thickest point, in millimeters. This is important for prognosis. For example, a thicker melanoma has a poorer prognosis. Breslow thickness is more important than the tumor’s Clark’s Level in figuring out the prognosis.
  • #3 Melanoma Diagnosis: Biopsy, Genetic Testing & Other Tests
    https://www.cancercenter.com/cancer-types/melanoma/diagnosis-and-detection
    If your dermatologist notices a suspicious-looking mole, a skin biopsy is usually warranted. Your doctor will remove as much of the suspicious area as possible and send it to a lab for analysis. […] Newer types of virtual biopsies can be done without needles, using a 3D imaging technique, called reflectance confocal microscopy, to capture images of suspicious lesions. This technology is both painless and non-invasive. […] If youre diagnosed with melanoma, your doctor may also perform some tests to determine whether the cancer has spread beyond the skin. […] The first place that melanomas usually spread is to nearby lymph nodes, so your doctor may feel under the arms, around your head and neck or in your groin area to determine whether any lymph nodes are enlarged. […] There are certain key tests done on biopsy samples to help make a melanoma diagnosis, including:
  • #3 Melanoma Stages 0, 1, 2, 3 and 4 Metastatic | Memorial Sloan Kettering Cancer Center
    https://www.mskcc.org/cancer-care/types/melanoma/diagnosis/melanoma-stages
    Stage I melanoma includes all melanomas that are in an early stage. Staging is based on the tumors thickness and whether the skin is broken (ulcerated). […] What is Stage 2 Melanoma? Melanoma at stage 2 is invasive. It has grown below the thin outer layer of the skin to the next layer of skin. It has not spread to lymph nodes. […] Stage 2 melanoma also is broken down into stages 2A, 2B, and 2C. The stage is based on the melanomas thickness and whether or not there is ulceration (broken skin). […] What is Stage 3 Melanoma? Stage 3 melanoma most often describes cancer that has metastasized (spread) to nearby lymph nodes. […] It can also mean melanoma that has spread beyond the primary tumor within the skin. It has not spread to the nearest lymph nodes. […] Stage 4 melanoma has metastasized (spread) farther from the primary site. Its beyond the area of nearby lymph nodes. It can be in areas such as the liver, lungs, brain, bone, or gastrointestinal tract. […] Melanoma can be stage 4 when its first diagnosed. Stage 4 melanoma can also be recurrent melanoma. Recurrent means the melanoma has come back after treatment. The cancer can come back where it first started, in the lymph nodes, or in a distant area.
  • #3 Melanoma: Diagnosis & Treatment | NewYork-Presbyterian
    https://www.nyp.org/cancer/melanoma/treatment
    How Is Melanoma Diagnosed? Diagnosis Early detection of melanoma can greatly increase the odds of successful treatment. A melanoma diagnosis can be determined with the following tests and procedures: […] A doctor or dermatologist will check your skin and scalp for signs of unusually shaped moles or other signs of melanoma, and inquire about your personal and family history. […] If cancer is detected in a biopsy, these additional tests may be used to determine the stage of melanoma: […] For melanomas deeper than 0.8 mm, this type of biopsy can determine if it has spread to the lymph nodes. […] CT scans can reveal if melanoma has spread to any internal organs. […] MRI scans are used to see if melanoma has spread to the spinal cord or brain. […] This scan can detect the presence of melanoma in the lymph nodes or other metastasis throughout the body. […] Melanoma is traditionally treated with surgery, chemotherapy, radiation therapy, immunotherapy, and targeted therapy. […] If detected early, melanoma has a cure rate of 99%. […] Left untreated, melanoma can be deadly.
  • #3 Metastatic Melanoma Diagnosis: Tests
    https://www.webmd.com/melanoma-skin-cancer/skin-stage-iv-diagnosis
    After your doctor says you have melanoma skin cancer, your first question is probably going to be: Has it spread? […] Your doctor will do tests to find out if it has moved, or metastasized, deeper within your skin or to other parts of your body. […] Even with that information, youll need to get some tests done to find out if its metastatic melanoma. […] A surgical oncologist may sample nearby lymph nodes to test for spreading tumor. […] It’s a type of biopsy that you can get done in your doctors office. […] It checks large lymph nodes near the skins surface and near the melanoma to see if the cancer has spread there. […] If those nodes contain melanoma cells, the cancer has likely spread. […] Ultrasound: This uses sound waves to create a picture of the inside of your body, including collections of lymph nodes.
  • #3 LCD – MolDX: Molecular Assays for the Diagnosis of Cutaneous Melanoma (L39389)
    https://www.cms.gov/medicare-coverage-database/view/lcd.aspx?lcdid=39389&ver=3
    Overall, clinical studies have shown sensitivity and specificity ranges of 90-94% and 91-96%, respectively, for the 23-GEP. […] A clinical utility study quantified the influence of the myPath Melanoma score on both the final diagnoses and the treatment recommendations made by board-certified dermatopathologists for diagnostically challenging melanocytic neoplasms encountered during routine clinical practice. […] DecisionDx DiffDx-Melanoma is a 35-gene expression profile (35-GEP) performed on FFPE tissue that is intended to discern benign from malignant melanocytic lesions. […] Other diagnostic adjuncts for melanocytic neoplasms include immunohistochemistry (IHC) to detect expression of the melanoma-associated antigen PRAME as well as tests that rely upon the detection of chromosomal aberrations within neoplastic melanocytes. […] The National Comprehensive Cancer Network (NCCN) Guidelines also support ancillary diagnostic testing (including with GEPs) to better classify melanocytic neoplasms of uncertain diagnostic potential.
  • #3 Melanoma | Better Health Channel
    https://www.betterhealth.vic.gov.au/health/conditionsandtreatments/melanoma
    Melanoma can grow very quickly. It can become life-threatening in as little as 6 weeks and, if untreated, it can spread to other parts of the body. […] Once a melanoma is diagnosed and treated, you are advised to have regular skin checks, as there is an increased risk of further melanomas developing.
  • #3 Melanoma Diagnosis and Treatment – A Detailed Guide
    https://www.hcgoncology.com/types-of-cancers/melanoma-diagnosis-and-treatment/
    Positron Emission Tomography (PET) scans help detect abnormal metabolic activity in the body, which can be indicative of cancerous growth. […] A blood test for melanoma cancer diagnosis may be recommended to evaluate the levels of vital components and assess the functions of various organs. […] Treatment typically involves surgical removal through wide local excision. […] Surgery, usually wide local excision, is the primary treatment for stage 2 melanoma. […] Treatment at this stage is more complex, often involving wide local excision, lymph node dissection, and possibly adjuvant therapy. […] Adjuvant therapy is considered after primary melanoma cancer treatment to target any remaining cancer cells and reduce the risk of recurrence. […] Immunotherapy is a revolutionary treatment approach that harnesses the body’s immune system to combat melanoma.
  • #3 Diagnosis and management of cutaneous melanoma
    https://www1.racgp.org.au/ajgp/2020/november/diagnosis-and-management-of-cutaneous-melanoma
    An appropriate wide local excision (WLE) is definitive treatment for most patients presenting with in situ or early-stage melanomas. […] SNB is the most sensitive method of detecting microscopic nodal disease at diagnosis, and it is recommended as a staging procedure for melanoma. […] A negative SNB provides reassurance that the risk of death from melanoma is low. […] Completion lymphadenectomy following a positive SNB is no longer recommended in most cases on the basis of results of the MSLT-II and DeCOG-SLT studies. […] New systemic therapies have been shown to be effective for both patients with advanced disease and those in the adjuvant setting, reducing the rate of recurrence in high-risk patients such as those who are SNB-positive. […] Early diagnosis of melanomas and appropriate initial management and follow-up are of great importance, and GPs play a critical part in this.
  • #4 Melanoma and Skin Cancer Symptoms and Diagnosis | UPMC
    https://hillman.upmc.com/cancer-care/melanoma-skin/symptoms-diagnosis
    Punch biopsy: Doctors use a round tool to remove the mole and some surrounding tissue. The sample is about the size of a pencil eraser. If the sample is large, you may have stitches to close the biopsy site. […] Incisional biopsy: Doctors remove only the irregular part of a mole. They may use this test when they’re unable to remove the entire growth due to its location.
  • #4 LCD – MolDX: Molecular Assays for the Diagnosis of Cutaneous Melanoma (L39389)
    https://www.cms.gov/medicare-coverage-database/view/lcd.aspx?lcdid=39389&ver=3
    Overall, clinical studies have shown sensitivity and specificity ranges of 90-94% and 91-96%, respectively, for the 23-GEP. […] A clinical utility study quantified the influence of the myPath Melanoma score on both the final diagnoses and the treatment recommendations made by board-certified dermatopathologists for diagnostically challenging melanocytic neoplasms encountered during routine clinical practice. […] DecisionDx DiffDx-Melanoma is a 35-gene expression profile (35-GEP) performed on FFPE tissue that is intended to discern benign from malignant melanocytic lesions. […] Other diagnostic adjuncts for melanocytic neoplasms include immunohistochemistry (IHC) to detect expression of the melanoma-associated antigen PRAME as well as tests that rely upon the detection of chromosomal aberrations within neoplastic melanocytes. […] The National Comprehensive Cancer Network (NCCN) Guidelines also support ancillary diagnostic testing (including with GEPs) to better classify melanocytic neoplasms of uncertain diagnostic potential.
  • #4 Understanding Your Pathology Report: Melanoma | OncoLink
    https://www.oncolink.org/cancers/skin/melanoma/treatments/understanding-your-pathology-report-melanoma
    Clark’s Level (also called anatomic level) measures the depth of the melanoma. It tells you what layer of the skin the melanoma has grown into, and does not give a measurement in millimeters. […] The melanoma lesion has RGP present or absent. If present, RGP means that the melanoma is growing horizontally within a single layer of skin. […] If present, it means that the melanoma is growing vertically or deeper into the tissues. VGP melanomas are invasive and may metastasize (spread to other areas). […] TILs look at your immune response to the melanoma. […] Ulceration happens when the skin sloughs (peels away). This can sometimes happen in the center of a melanoma lesion. If there is ulceration, it goes into the staging of a melanoma. […] Regression is either present or absent. […] Higher mitotic rates are linked with more rapidly dividing cells and larger lesions, with a greater chance of metastasis.
  • #4 Melanoma Diagnosis: Biopsy, Genetic Testing & Other Tests
    https://www.cancercenter.com/cancer-types/melanoma/diagnosis-and-detection
    This test uses antibodies to check for antigens or markers in the tissue sample that indicate the presence of cancer cells. […] The GEP test can find the root of and diagnose a disease and determine how well the body may respond to treatment. A melanoma biopsy may be tested for mutations in certain genes because this information can help guide treatment decisions. […] Several medical imaging procedures, including a computed tomography (CT) scan, magnetic resonance imaging (MRI), positron emission tomography-computed tomography (PET-CT) scan or X-ray, may be used to detect cancer cells or tumors throughout the body. […] Your doctor may suggest testing your biopsy sample to see whether the cells express changes in certain genes. […] This information can help guide treatment decisions. Some newer drugs, such as BRAF inhibitors used to treat spreading melanomas, only work if the cells have BRAF mutations. […] Another gene test, DecisionDx-Melanoma, examines certain gene expression patterns in melanoma cells and can help you and your care team determine whether an early-stage melanoma is likely to spread or return, which can help further guide treatment options.
  • #4 Metastatic Melanoma Diagnosis: Tests
    https://www.webmd.com/melanoma-skin-cancer/skin-stage-iv-diagnosis
    If the melanoma has spread, it can show the size of a tumor. […] MRI (magnetic resonance imaging): It uses powerful magnets and radio waves to make pictures of organs and structures inside your body. […] For melanoma, an MRI can detect the tumor and measure its size. […] PET scan (positron emission tomography): For this test, you’ll get an injection of a small amount of radioactive substance (likely a sugar related to glucose) that helps light up quick-growing cancer cells that absorb glucose.
  • #4 Melanoma Diagnosis and Treatment – A Detailed Guide
    https://www.hcgoncology.com/types-of-cancers/melanoma-diagnosis-and-treatment/
    Targeted therapy focuses on specific molecules involved in the growth and spread of melanoma cells. […] Radiation therapy utilizes high-energy rays to target and destroy cancer cells. […] While less commonly used than in the past, chemotherapy may be prescribed in certain cases of melanoma. […] Palliative and supportive care plays a crucial role in melanoma treatment, especially in advanced stages. […] The treatment of melanoma varies by stage, ranging from surgical interventions to adjuvant therapies. Early detection, personalized treatment plans, and ongoing surveillance are crucial elements in managing melanoma effectively. […] A definitive diagnosis of melanoma often requires a dermatologist or an oncologist with expertise in skin cancer. […] Routine blood tests are not typically used for melanoma detection. The primary diagnostic method is a skin biopsy, where a sample of suspicious tissue is examined under a microscope.